Abstract
Background/Aims
Soft tissue sarcomas (STS) are rare tumors. General treatment is difficult while multimodality treatment strategies are more and more common. In these strategies, surgical resection of the primary tumor is essential to achieve local control of the tumor. In certain cases, complex resections (CR) including multivisceral and/or vascular resection are needed to achieve resection with tumor-free margins. In this study, we evaluated retrospectively the overall prognosis, morbidity, and mortality of patients treated for STS at our university hospital.
Patients/Methods
Between 1992 and 2000, 24 of 154 patients with STS received multivisceral resection and four of 154 underwent vascular resection. To determine the influence of CR on overall prognosis, we compared n = 19 patients after CR with a matched control group after simple tumor resection (SR). To determine surgical morbidity and mortality the whole study group was used (n = 154, SR n = 126, CR n = 28).
Results
The median follow up for all patients was 6.89 years (mean 5.64 years SD 4.3) with no difference between the groups (CR vs SR: 5.4 SD 4.8 vs 5.9 SD 3.9 years; p = 0.711). Patients receiving CR had a similar overall prognosis (mean survival 9.9 years), morbidity (10.7%) and mortality (0%) compared to patients with SR (mean survival 8.5 years; morbidity 10.3%; mortality 3.96%).
Conclusions
Multivisceral resection and/or vascular resection with tumor-free margins can be achieved with the same overall prognosis, same morbidity and mortality as SR. This has to be taken into account when evaluating the treatment strategy in patients with STS.
Similar content being viewed by others
References
Nijhues PH, Schaapveld M, Otter R (1999) Epidemiological aspects of soft tissue sarcomas (STS)—consequences for the design of clinical STS trials. Eur J Cancer 35:1705–1710 doi:10.1016/S0959-8049(99)00152-5
Lewis JJ, Benedetti F (1997) Adjuvant therapy for soft tissue sarcomas. Surg Oncol N Am 6:847–862
Sampo M, Tarkkanen M, Huuthanen R, Tukiainen E, Böhling T, Blomqvist C (2008) Impact of smallest surgical margin on local control in soft tissue sarcoma. Br J Surg 95:237–243 doi:10.1002/bjs.5906
Wong S, Brennan MF (2004) Therapeutisches management intraabdomineller und retroperitonealer Weichgewebssarkome. Chirurg 75:1174–1181 doi:10.1007/s00104-004-0961-2
Ghert MA, Davis AM, Griffin AM, Alyami AH, White L, Kandel RA et al (2005) The surgical and functional outcome of limb salvage surgery with vascular reconstruction for soft tissue sarcoma of the extremity. Ann Surg Oncol 12:1102–1110 doi:10.1245/ASO.2005.06.036
Hohenberger P (1998) Chirurgische Technik und chirurgisch-onkologische Taktik bei Tumoren der Weichgewebe und Extremitäten mit Gefäßbeteiligung. Chirurg 69:19–27 doi:10.1007/s001040050369
Karakousis CP, Karmpaliotis C, Driscoll DL (1996) Major vessel resection during limb-preserving surgery for soft tissue sarcomas. World J Surg 20:345–350 doi:10.1007/s002689900056
Dzierwinsky W, Rutkowsky P, Zbigniew IN, Salammacha M, Morysinski T, Kulik A, Kawezynska M, Kasprowicz A, Lyczek J, Ruka W (2006) Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas. Ann Surg Oncol 13:245–252 doi:10.1245/ASO.2006.03.026
Porter GA, Baxter NN, Pisters PW (2006) Retroperitoneal sarcoma. A population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 106:1610–1616 doi:10.1002/cncr.21761
Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Bul BN, French Federation of Cancer Center Sarcoma Group (2001) Prognostic factors in retroperitoneal sarcoma. Cancer 92:359–368 doi:10.1002/1097-0142(20010715)92:2<359::AID-CNCR1331>3.0.CO;2-Y
Lewis JJ, Leung D, Woodruff JM, Brennan MF (1998) Retroperitoneal soft tissue sarcoma. Analysis of 500 patients treated and followed at a single institution. Ann Surg 228:355–365 doi:10.1097/00000658-199809000-00008
Karakousis CP, Gerstenblut R, Kontzoglou K, Driscoll DL (1995) Retroperitoneal sarcomas and their management. Arch Surg 130:1104–1109
Fortner JG, Kim DK, Shiu MH (1977) Limb-preserving vascular surgery for malignant tumors oft he lower extremity. Arch Surg 112:391–394
Schwarzbach MHM, Hormann Y, Hinz U, Bernd L, Willeke F, Mechterseimer G et al (2005) Results of limb-sparing surgery with vascular replacement for soft tissue sarcoma in the lower extremity. J Vasc Surg 42:88–97 doi:10.1016/j.jvs.2005.03.017
Hohenberger P, Allenberg JR, Schlag PM, Reichardt P (1999) Results of surgery and multimodal therapy for patients with soft tissue sarcoma invading to vascular structures. Cancer 85:396–408 doi:10.1002/(SICI)1097-0142(19990115)85:2<396::AID-CNCR18>3.0.CO;2-O
Bianchi C, Ballard JL, Bergan JH, Killeen JD (1999) Vascular reconstruction and major resection for malignancy. Arch Surg 134:851–855 doi:10.1001/archsurg.134.8.851
Bevilacqua RG, Rogatko A, Hajdu SI, Brennan MF (1991) Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg 126:328–334
Singer S, Antonescu CR, Riedel E, Brennan MF (2003) Histologic subtype and margin of resection predict pattern and survival for retroperitoneal liposarcoma. Ann Surg 238:358–371
Hassan I, Park SZ, Donohue JH, Nagoney DM, Kay PA, Nasciemento AG et al (2004) Operative management of primary retroperitoneal sarcomas. A reappraisal of an institutional experience. Ann Surg 239:244–250 doi:10.1097/01.sla.0000108670.31446.54
Hoekstra HJ, Thijssens K, van Ginkel RJ (2004) Role of surgery as primary treatment and as intervention in the multidisciplinary treatment of soft tissue sarcoma. Ann Oncol 15:181–186 doi:10.1093/annonc/mdh077
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Vogel, P., Bolder, U., Scherer, M.N. et al. Long-term outcome after multivisceral and tumor/vascular resection in patients with soft tissue sarcoma. Langenbecks Arch Surg 394, 331–337 (2009). https://doi.org/10.1007/s00423-008-0403-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-008-0403-6